Bone Marrow Transplantation Market Size Share Growth & Forecast 2024-2031

Bone Marrow Transplantation Market Size, Share, Industry, Forecast and Outlook (2024-2031)

<h2>Global Bone Marrow Transplantation Market&nbsp;is segmented By Transplantation Type (Autologous Bone Marrow Transplantation, Allogenic Bone Marrow Transplantation) By Disease Indication (Leukemia, Lymphoma, Myeloma, Anemia, Others) By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers)&nbsp;and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2024-2031</h2>

<h3>Market Overview</h3>

<blockquote>
Global Bone Marrow Transplantation Market reached US$ YY&nbsp;million in 2023 and is expected to reach US$ YY&nbsp;million by 2031, growing with a CAGR of YY% during the forecast period 2024-2031.
</blockquote>

Bone marrow transplantation (BMT), also known as hematopoietic stem cell transplantation (HSCT), is a medical procedure used primarily to treat certain cancers like leukemia, lymphoma, and multiple myeloma, as well as certain non-cancerous conditions such as aplastic anemia and sickle cell disease. The procedure involves replacing damaged or diseased bone marrow with healthy bone marrow stem cells.

Patients require close monitoring during the recovery period, which can last for several months. They may need blood transfusions, antibiotics to prevent infections, and other supportive care. Regular follow-up visits are necessary to monitor progress and manage any complications. Advances in transplantation techniques, supportive care, and donor matching have improved the success rates of bone marrow transplantation over the years, making it a potentially curative treatment for many patients with certain types of cancer and other disorders.

<h3>Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Size Available for Years
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2022-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2024-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Data Availability
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Transplantation Type, Disease Indication, End-User
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Growing Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Region
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more details of the report -&nbsp;<a href="https://www.datamintelligence.com/download-sample/bone-marrow-transplantation-market" target="_blank">Request for sample</a>

&nbsp;

<h3>Market Dynamics: Drivers and Restraints</h3>

Rising technological advancements in transplantation techniques

Rising technological advancements in transplantation techniques play a crucial role in driving the bone marrow transplantation market by improving transplant outcomes, expanding the pool of eligible patients, and reducing treatment-related complications. For instance, technologies for stem cell collection, such as apheresis systems and improved methods for mobilizing stem cells from the bone marrow, enable efficient and high-yield harvesting of stem cells from both donors and patients.&nbsp;

Additionally, advancements in cryopreservation techniques ensure the long-term viability of stem cell products, facilitating their storage and transportation for transplantation. Moreover, innovations in infection control practices, such as improved screening methods and targeted antimicrobial therapies, contribute to better patient outcomes and higher transplant success rates.&nbsp;

Furthermore, techniques for graft manipulation, including ex vivo T-cell depletion, selective depletion of alloreactive T-cells, and T-cell receptor (TCR) &alpha;&beta; depletion, help reduce the risk of GVHD and graft rejection while preserving graft-versus-leukemia (GVL) effects. Furthermore, graft engineering approaches, such as chimeric antigen receptor (CAR) T-cell therapy and gene editing technologies like CRISPR-Cas9, hold promise for enhancing the efficacy and safety of BMT in the future.

Market Dynamics: Restraint

Limited donor availability

Matching the human leukocyte antigen (HLA) type between the donor and recipient is crucial for reducing the risk of graft rejection and graft-versus-host disease (GVHD). However, patients from ethnically diverse populations often face challenges in finding suitable HLA-matched donors due to the underrepresentation of certain ethnic groups in donor registries.&nbsp;

Donor registries, such as the National Marrow Donor Program (NMDP) in the United States and similar organizations worldwide, rely on voluntary donor recruitment to maintain their databases of potential stem cell donors. Despite efforts to expand donor registries, the size and diversity of donor pools remain limited in many regions, particularly in countries with smaller populations or underdeveloped healthcare systems. This shortage of registered donors reduces the likelihood of finding suitable matches for patients in need of transplantation.

<h3>Segment Analysis</h3>

The global bone marrow transplantation market is segmented based on transplantation type, disease indication, end-user and region.

The autologous bone marrow transplantation from the Disease Indication&nbsp; segment accounted for approximately 61.18% of share

The rise of the autologous bone marrow transplantation segment has contributed to the growth of the bone marrow transplantation market by offering a viable treatment option for certain diseases, overcoming limitations associated with allogeneic transplantation. For instance, in multiple myeloma, high-dose chemotherapy followed by autologous stem cell transplantation has become a standard of care, leading to improved survival outcomes and disease control. The increasing incidence of solid tumors and the expanding use of autologous BMT in their treatment contribute to market growth.

Additionally, ongoing research and clinical trials are exploring the use of autologous BMT in novel therapeutic applications, including regenerative medicine, tissue engineering, and gene therapy. For instance, autologous stem cells may be used to repair damaged tissues, regenerate organs, or deliver gene therapies for inherited disorders. The potential of autologous BMT in these emerging fields drives investment, innovation, and segment expansion in the autologous bone marrow transplantation.

<h3>Geographical Analysis</h3>

North America accounted for approximately 41.28% of the market share in 2022

North America is at the forefront of technological innovation in the field of transplantation medicine. Advanced techniques for stem cell collection, donor matching, conditioning regimens, and supportive care have improved transplant outcomes and expanded the eligibility criteria for BMT. For instance, the development of novel mobilizing agents, such as plerixafor, and the widespread adoption of apheresis technology have facilitated efficient stem cell collection, enhancing the feasibility and success of transplantation procedures in the region.

Additionally, key product launches, acquisition &amp; partnerships among major players, and increasing United States are some of the factors driving the growth of the hematopoietic stem cell transplantation market in the country. For instance, according to the data published by the Leukemia and Lymphoma Society&#39;s facts and Statistics, around 90,390 people in the United States were expected to be diagnosed with lymphoma in 2021 (8,830 Hodgkin Lymphoma cases of and 81,560 cases of Non-Hodgkin Lymphoma). Moreover, the availability of insurance coverage and favorable reimbursement policies remove barriers to access and encourage utilization of BMT services, contributing to market growth in the region.

<h3>COVID-19 Impact Analysis</h3>

The COVID-19 pandemic posed challenges to donor recruitment efforts, particularly for unrelated donor registries and volunteer donor organizations. Donor drives, recruitment events, and community outreach activities were disrupted or postponed due to social distancing guidelines and public health restrictions. As a result, there was a decline in the registration of new donors, potentially reducing the pool of available donors for patients in need of allogeneic transplantation.

The COVID-19 pandemic disrupted clinical trials and research activities in the field of transplantation medicine. Many research studies were paused or modified to prioritize COVID-19-related research or to comply with public health guidelines. Clinical trials evaluating novel transplantation techniques, immunosuppressive therapies, and supportive care interventions were affected, leading to delays in the development of new treatments and therapies for BMT recipients.

<h3>Competitive Landscape</h3>

The major global players in the market include Thermo Fisher Scientific, Fresenius Kabi, Medtronic, Stryker Corporation, GE Healthcare, Mindray, Baxter International Inc, B. Braun SE, Sanofi, BD Biosciences among others.

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global bone marrow transplantation market segmentation based on transplantation type, disease indication, end-user and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of bone marrow transplantation market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global bone marrow transplantation market report would provide approximately 69 tables, 58 figures and 187 Pages.

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Transplantation Type</li>
		<li>Snippet by Disease Indication</li>
		<li>Snippet by End-User</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Market Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Rising technological advancements in transplantation techniques</li>
				<li>Increasing adoption of allogeneic transplants&nbsp;</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Restraints
		<ol>
			<li>Limited donor availability</li>
		</ol>

		<ol>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Unmet Needs</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Transplantation Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Transplantation Type</li>
			<li>Market Attractiveness Index, By Transplantation Type</li>
		</ol>
		</li>
		<li>Autologous Bone Marrow Transplantation *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Allogenic Bone Marrow Transplantation</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Disease Indication</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication</li>
			<li>Market Attractiveness Index, By Disease Indication</li>
		</ol>
		</li>
		<li>Leukemia *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Lymphoma</li>
		<li>Myeloma</li>
		<li>Anemia</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By End-User</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Attractiveness Index, By End-User</li>
		</ol>
		</li>
		<li>Hospitals *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Specialty Clinics</li>
		<li>Ambulatory Surgical Centers</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Transplantation Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Transplantation Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Transplantation Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Transplantation Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>South Korea</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Transplantation Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Thermo Fisher Scientific *
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Fresenius Kabi</li>
		<li>Medtronic</li>
		<li>Stryker Corporation</li>
		<li>GE Healthcare</li>
		<li>Mindray</li>
		<li>Baxter International Inc</li>
		<li>B. Braun SE</li>
		<li>Sanofi</li>
		<li>BD Biosciences&nbsp;(LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global Bone Marrow Transplantation Market Value, By Transplantation Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 2 Global Bone Marrow Transplantation Market Value, By Disease Indication, 2023, 2027 &amp; 2031 (US$ Million)

Table 3 Global Bone Marrow Transplantation Market Value, By End User, 2023, 2027 &amp; 2031 (US$ Million)

Table 4 Global Bone Marrow Transplantation Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 5 Global Bone Marrow Transplantation Market Value, By Transplantation Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 6 Global Bone Marrow Transplantation Market Value, By Transplantation Type, 2022-2031 (US$ Million)

Table 7 Global Bone Marrow Transplantation Market Value, By Disease Indication, 2023, 2027 &amp; 2031 (US$ Million)

Table 8 Global Bone Marrow Transplantation Market Value, By Disease Indication, 2022-2031 (US$ Million)

Table 9 Global Bone Marrow Transplantation Market Value, By End User, 2023, 2027 &amp; 2031 (US$ Million)

Table 10 Global Bone Marrow Transplantation Market Value, By End User, 2022-2031 (US$ Million)

Table 11 Global Bone Marrow Transplantation Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 12 Global Bone Marrow Transplantation Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Bone Marrow Transplantation Market Value, By Transplantation Type, 2022-2031 (US$ Million)

Table 14 North America Bone Marrow Transplantation Market Value, By Disease Indication, 2022-2031 (US$ Million)

Table 15 North America Bone Marrow Transplantation Market Value, By End User, 2022-2031 (US$ Million)

Table 16 North America Bone Marrow Transplantation Market Value, By Country, 2022-2031 (US$ Million)

Table 17 Asia-Pacific Bone Marrow Transplantation Market Value, By Transplantation Type, 2022-2031 (US$ Million)

Table 18 Asia-Pacific Bone Marrow Transplantation Market Value, By Disease Indication, 2022-2031 (US$ Million)

Table 19 Asia-Pacific Bone Marrow Transplantation Market Value, By End User, 2022-2031 (US$ Million)

Table 20 Asia-Pacific Bone Marrow Transplantation Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Bone Marrow Transplantation Market Value, By Transplantation Type, 2022-2031 (US$ Million)

Table 22 Europe Bone Marrow Transplantation Market Value, By Disease Indication, 2022-2031 (US$ Million)

Table 23 Europe Bone Marrow Transplantation Market Value, By End User, 2022-2031 (US$ Million)

Table 24 Europe Bone Marrow Transplantation Market Value, By Country, 2022-2031 (US$ Million)

Table 25 South America Bone Marrow Transplantation Market Value, By Transplantation Type, 2022-2031 (US$ Million)

Table 26 South America Bone Marrow Transplantation Market Value, By Disease Indication, 2022-2031 (US$ Million)

Table 27 South America Bone Marrow Transplantation Market Value, By End User, 2022-2031 (US$ Million)

Table 28 South America Bone Marrow Transplantation Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East and Africa Bone Marrow Transplantation Market Value, By Transplantation Type, 2022-2031 (US$ Million)

Table 30 Middle East and Africa Bone Marrow Transplantation Market Value, By Disease Indication, 2022-2031 (US$ Million)

Table 31 Middle East and Africa Bone Marrow Transplantation Market Value, By End User, 2022-2031 (US$ Million)

Table 32 Middle East and Africa Bone Marrow Transplantation Market Value, By Country, 2022-2031 (US$ Million)

Table 33 Thermo Fisher Scientific: Overview

Table 34 Thermo Fisher Scientific: Product Portfolio

Table 35 Thermo Fisher Scientific: Key Developments

Table 36 Fresenius Kabi: Overview

Table 37 Fresenius Kabi: Product Portfolio

Table 38 Fresenius Kabi: Key Developments

Table 39 Medtronic: Overview

Table 40 Medtronic: Product Portfolio

Table 41 Medtronic: Key Developments

Table 42 Stryker Corporation: Overview

Table 43 Stryker Corporation: Product Portfolio

Table 44 Stryker Corporation: Key Developments

Table 45 GE Healthcare: Overview

Table 46 GE Healthcare: Product Portfolio

Table 47 GE Healthcare: Key Developments

Table 48 Mindray: Overview

Table 49 Mindray: Product Portfolio

Table 50 Mindray: Key Developments

Table 51 Baxter International Inc: Overview

Table 52 Baxter International Inc: Product Portfolio

Table 53 Baxter International Inc: Key Developments

Table 54 B. Braun SE: Overview

Table 55 B. Braun SE: Product Portfolio

Table 56 B. Braun SE: Key Developments

Table 57 Sanofi: Overview

Table 58 Sanofi: Product Portfolio

Table 59 Sanofi: Key Developments

Table 60 BD Biosciences: Overview

Table 61 BD Biosciences: Product Portfolio

Table 62 BD Biosciences: Key Developments

List of Figures

Figure 1 Global Bone Marrow Transplantation Market Value, 2022-2031 (US$ Million)

Figure 2 Global Bone Marrow Transplantation Market Share, By Transplantation Type, 2023 &amp; 2031 (%)

Figure 3 Global Bone Marrow Transplantation Market Share, By Disease Indication, 2023 &amp; 2031 (%)

Figure 4 Global Bone Marrow Transplantation Market Share, By End User, 2023 &amp; 2031 (%)

Figure 5 Global Bone Marrow Transplantation Market Share, By Region, 2023 &amp; 2031 (%)

Figure 6 Global Bone Marrow Transplantation Market Y-o-Y Growth, By Transplantation Type, 2023-2031 (%)

Figure 7 Autologous Bone Marrow Transplantation Bone Marrow Transplantation Market Value, 2022-2031 (US$ Million)

Figure 8 Allogenic Bone Marrow Transplantation Bone Marrow Transplantation Market Value, 2022-2031 (US$ Million)

Figure 9 Global Bone Marrow Transplantation Market Y-o-Y Growth, By Disease Indication, 2023-2031 (%)

Figure 10 Leukemia Disease Indication in Global Bone Marrow Transplantation Market Value, 2022-2031 (US$ Million)

Figure 11 Lymphoma Disease Indication in Global Bone Marrow Transplantation Market Value, 2022-2031 (US$ Million)

Figure 12 Myeloma Disease Indication in Global Bone Marrow Transplantation Market Value, 2022-2031 (US$ Million)

Figure 13 Anemia Disease Indication in Global Bone Marrow Transplantation Market Value, 2022-2031 (US$ Million)

Figure 14 Others Disease Indication in Global Bone Marrow Transplantation Market Value, 2022-2031 (US$ Million)

Figure 15 Global Bone Marrow Transplantation Market Y-o-Y Growth, By End User, 2023-2031 (%)

Figure 16 Hospitals End User in Global Bone Marrow Transplantation Market Value, 2022-2031 (US$ Million)

Figure 17 Specialty Clinics End User in Global Bone Marrow Transplantation Market Value, 2022-2031 (US$ Million)

Figure 18 Ambulatory Surgical Centers End User in Global Bone Marrow Transplantation Market Value, 2022-2031 (US$ Million)

Figure 19 Global Bone Marrow Transplantation Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 20 North America Bone Marrow Transplantation Market Value, 2022-2031 (US$ Million)

Figure 21 North America Bone Marrow Transplantation Market Share, By Transplantation Type, 2023 &amp; 2031 (%)

Figure 22 North America Bone Marrow Transplantation Market Share, By Disease Indication, 2023 &amp; 2031 (%)

Figure 23 North America Bone Marrow Transplantation Market Share, By End User, 2023 &amp; 2031 (%)

Figure 24 North America Bone Marrow Transplantation Market Share, By Country, 2023 &amp; 2031 (%)

Figure 25 Asia-Pacific Bone Marrow Transplantation Market Value, 2022-2031 (US$ Million)

Figure 26 Asia-Pacific Bone Marrow Transplantation Market Share, By Transplantation Type, 2023 &amp; 2031 (%)

Figure 27 Asia-Pacific Bone Marrow Transplantation Market Share, By Disease Indication, 2023 &amp; 2031 (%)

Figure 28 Asia-Pacific Bone Marrow Transplantation Market Share, By End User, 2023 &amp; 2031 (%)

Figure 29 Asia-Pacific Bone Marrow Transplantation Market Share, By Country, 2023 &amp; 2031 (%)

Figure 30 Europe Bone Marrow Transplantation Market Value, 2022-2031 (US$ Million)

Figure 31 Europe Bone Marrow Transplantation Market Share, By Transplantation Type, 2023 &amp; 2031 (%)

Figure 32 Europe Bone Marrow Transplantation Market Share, By Disease Indication, 2023 &amp; 2031 (%)

Figure 33 Europe Bone Marrow Transplantation Market Share, By End User, 2023 &amp; 2031 (%)

Figure 34 Europe Bone Marrow Transplantation Market Share, By Country, 2023 &amp; 2031 (%)

Figure 35 South America Bone Marrow Transplantation Market Value, 2022-2031 (US$ Million)

Figure 36 South America Bone Marrow Transplantation Market Share, By Transplantation Type, 2023 &amp; 2031 (%)

Figure 37 South America Bone Marrow Transplantation Market Share, By Disease Indication, 2023 &amp; 2031 (%)

Figure 38 South America Bone Marrow Transplantation Market Share, By End User, 2023 &amp; 2031 (%)

Figure 39 South America Bone Marrow Transplantation Market Share, By Country, 2023 &amp; 2031 (%)

Figure 40 Middle East and Africa Bone Marrow Transplantation Market Value, 2022-2031 (US$ Million)

Figure 41 Middle East and Africa Bone Marrow Transplantation Market Share, By Transplantation Type, 2023 &amp; 2031 (%)

Figure 42 Middle East and Africa Bone Marrow Transplantation Market Share, By Disease Indication, 2023 &amp; 2031 (%)

Figure 43 Middle East and Africa Bone Marrow Transplantation Market Share, By End User, 2023 &amp; 2031 (%)

Figure 44 Thermo Fisher Scientific: Financials

Figure 45 Fresenius Kabi: Financials

Figure 46 Medtronic: Financials

Figure 47 Stryker Corporation: Financials

Figure 48 GE Healthcare: Financials

Figure 49 Mindray: Financials

Figure 50 Baxter International Inc: Financials

Figure 51 B. Braun SE: Financials

Figure 52 Sanofi: Financials

Figure 53 BD Biosciences: Financials

Bone Marrow Transplantation Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Bone Marrow Aspirate Concentrates Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 08

Starting from

BONE Cancer Diagnosis Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 06

Starting from

Bone Morphogenetic Protein Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 March 19

Starting from